demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
COVID 19 all comers
anti-inflammatoty and immuno-therapy
Immunostimulants drugs
convalescent plasma treatment LIFESAVER
Immunosuppressants drugs
anti-interleukin-6
tocilizumab BACC Bay Tocilizumab Trial
janus kinase (JAK) inhibitor
baricitinib RECOVERY
leflunomide Wang

31 studies excluded by filtering options 0

4930 Huijie Bian, 2020 2313excludednot a RCThigh risk of bias
5282 Hung, 2017 010selection pending
5317 Lu, 2020 1223not a RCThigh risk of bias
5319 Wu, 2020 1133not a RCThigh risk of bias
5422 Wang et al., 2020 010selection pending
5443 Victor, 2020 000selection pending
5453 Raef, 2020 1134not a RCThigh risk of bias
5454 Jianfeng, 2020 1133not a RCThigh risk of bias
5455 Tomasz, 2020 1204not a RCThigh risk of bias
5456 Fernández Cruz, 2020 1133not a RCThigh risk of bias
5472 GLUCOCOVID, 2020 113high risk of bias
5476 Yuan, 2020 0130selection pending
5484 Salton (Methylprednisolone), 2020 0134selection pending
5485 openSafely, 2020 0130selection pending
5510 Malgorzata, 2020 1134not a RCThigh risk of bias
5552 Rahman, 2020 0130selection pending
5568 Zhang, 2020 0130selection pending
5603 Albani, 2020 0130selection pending
5612 Bernaola, 2020 2130excludednot a RCTrisk of bias not avaialble
5614 Monreal, 2020 0130selection pending
5615 Nelson (Methylprednisolone), 2020 0130selection pending
5639 Li (Methylprednisolone, Shanghai cohort), 2020 0130selection pending
5796 SAM-COVID-19, 2020 0130selection pending
5840 Majmundar, 2020 0130selection pending
5939 Li (Methylprednisolone, Validation cohort), 2020 0130selection pending
5952 Rodriguez-Bano (intermediate-high dose CS), 2020 0130selection pending
5953 Rodriguez-Bano (CS pulse dose), 2020 0130selection pending
6036 Esba, 2020 0100selection pending
6046 Husain, 2020 010selection pending
6048 Wu, 2020 0110selection pending
8158 Yildiz, 2021 210excludedrisk of bias not avaialble